The Indian Patent Office has begun hearing on the validity of a patent granted to Roche for Pegasys (pegylated interferon alfa 2a), a drug used to treat hepatitis C. Assistant controller of patents at the Chennai Patent Office heard the post-grant opposition filed by Sankalp Rehabilitation Trust against the patent.
The details can be read here.
No comments:
Post a Comment